Coronavirus India updates

  • The world needs pharmaceuticals from China and India to beat coronavirus The biggest pharmaceutical companies in the world, known as “big pharma”, are American and European. The top five are Pfizer (US), Roche, Novartis (both Swiss), Merck (US) and GlaxoSmithKline (UK). Yet these companies – and the pharmaceutical industry as a whole – rely on global supply chains. And China and India play key roles in the supply of both ingredients and finished drugs…read more
  • Coronavirus: Biocon Biologics gets DCGI approval for emergency use of CytoSorb to treat critical COVID-19 patients Biocon Ltd, a Bengaluru-based global biopharmaceuticals company, on Wednesday announced that its subsidiary Biocon Biologics has received the Drugs Controller General of India’s (DCGI) approval for an extracorporeal blood purification (EBP) device CytoSorb to reduce pro-inflammatory cytokines levels in confirmed COVID-19 patients admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure….read more
  • Coronavirus: India to loosen lockdown despite record cases India has announced plans to further ease a strict national lockdown even as the country reported a record daily rise in new coronavirus cases….read more
  • India needs to flatten more than just the coronavirus curve The spread of the coronavirus in India is showing no sign of abatement. Unless it catches a lucky break, Asia’s No. 1 pandemic hotspot is still a month or more away from a peak in infections (currently above 165,000) despite a severe lockdown. Tricky as the situation is for the country’s patchy healthcare infrastructure, the disease won’t be India’s only curve to flatten…..read more
  • A pandemic of democratic inertia As the economic toll from Covid-19 mounts, there have been a number of people pointing to past failures in funding public health, which has greatly increased our vulnerability. With some foresight, we could have built a healthcare system that is more resilient and able to withstand such large threats. To which it is added, at least now we must make the necessary investments in healthcare for the future….read more
  • Four or more dosage of HCQ helped health workers ward off Covid-19: ICMR Citing noteworthy benefits of Hydroxychloroquine (HCQ) prophylaxis against coronavirus, the Indian Council of Medical Research (ICMR) has revealed that the consumption of four or more doses of the antimalarial drug- (HCQ), has shown a significant decline of Covid-19 infection among health care workers (HCWs)…read more
  • DST initiates COVID-19 India National Supermodel for monitoring infection transmission & aid decision-making by policymakers The Department of Science and Technology (DST) has initiated a COVID -19 Indian National Supermodel to help monitor the future transmission of infection, thus aiding decisions involving health system readiness and other mitigation measures.…..read more
  • Scaling up of COVID testing centres (Hub and Spoke model) in National research laboratories and Universities To scale up testing and enhance the reach across the countryCity /Regional clusters have been established in a Hub and Spoke Model to scale-up testing of COVID-19 samples in government institutions across the country. Institutes and Laboratories which have the capacity and expertise for both sample collection, handling/processing (BSL-2 facility) and testing (RT-PCR) serve as the hubs and they involve a number of laboratories which have RT PCR machines and the requisite manpower as their extended Testing facilities…..read more
  • Ritonavir may inhibit exoribonuclease activity of nsp14 from the SARS-CoV-2 virus and potentiate the activity of chain terminating drugs Computational studies carried out at the DBT’s Regional Centre for Biotechnology (RCB), Faridabad suggests that the HIV-1 protease inhibitor named Ritonavir might bind to the exoribonuclease active site of the nsp14 protein, prevent association with substrate viral RNA and thus inhibits the proofreading activity of nsp14…read more
  • Incubatee ‘Shine Biotech Pvt Ltd’ at BBB selected for DBT-BIRAC grant for COVID-19 research To urgently develop safe and effective biomedical solutions against SARS CoV-2, the Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC) had invited applications for COVID-19 Research Consortium….read more
  • DBT-BIRAC clears proposal for a COVID-19 diagnostic Kit The Department of Biotechnology and its public sector undertaking Biotechnology Research Industry Research Council have selected Yaathum Biotech Pvt Ltd for funding support under DBT’s National Biopharma Mission for indigenous development and validation of a real-time RT-PCR based molecular test for COVID-19 diagnosis….read more
  • DBT-NIBMG scientists study the evolution of Coronavirus COVID-19 is a pandemic which has spread across the globe. Viruses are known to mutate over a period of time. Scientists at the Department of Biotechnology’s National Institute of BioMedical Genomics (DBT-NIBMG), Kalyani, have investigated how SARS-CoV-2 has evolved with the progression of the pandemic across countries over time….read more
  • DST-SERB supports study for identification of structure-based potential antivirals against COVID 19 The Science and Engineering Research Board (SERB) under the Department of Science & Technology (DST) has recently supported a proposed study by Prof. Pravindra Kumar from IIT-Roorkee for identification of structure-based potential antivirals against SARS-CoV2…read more
  • No major side-effects of HCQ in studies in India, can be used as preventive Covid treatment: ICMR No major side-effects of antimalarial drug Hydroxychloroquine (HCQ) have been found in studies in India and its use can be continued in preventive treatment for Covid-19 under strict medical supervision, the Indian Council of Medical Research (ICMR) said on Tuesday. The ICMR’s statement came against the backdrop of the World Health Organization (WHO) temporarily suspending the testing of the drug as a potential treatment for Covid-19 over safety concerns….read more
  • Global vaccines to get faster approval: Renu Swarup, Secretary, Department of Biotech India is in discussions with global health agencies to start a solidarity trial for vaccines, on the lines of the drug trial that the WHO started for potential Covid-19 treatments….read more
  • Early genome sequencing in India shows dominant Covid-19 strain matches global patterns A new examination of 327 genome sequences from India shows early signs of the growing dominance of one COVID-19 virus strain in the country. This subtype, called A2a, also shows a larger prevalence across the globe — crucial information for vaccine development and disease monitoring from Calcutta’s National Institute of Biomedical Genomics (NIBG)….read more